Regeneron Pharmaceuticals (NASDAQ:REGN) mentioned on Monday its bispecific antibody Ordspono (odronextamab) has been cleared by the European Commission for the therapy of relapsed/refractory follicular lymphoma and…
Author: Helitra.com
AdaptHealth appoints Barnhart as COO Source: Seekingalpha
Vericel (NASDAQ:VCEL) has introduced that the U.S. FDA has authorised a supplemental Biologics License Application increasing the MACI® label to incorporate arthroscopic supply of MACI to…
NRx Pharmaceuticals reports potential acquisition and financing agreements Source: Seekingalpha
BCFC/iStock Editorial through Getty Images McKesson (NYSE:MCK) stated it would acquire a controlling interest in Core Ventures for $2.49B in money. Core Ventures was established by…
Healthcare companies supplier Premier Inc (NASDAQ:PINC) was downgraded to Hold from Buy at Benchmark on Monday after the corporate guided its FY25-26 outlook beneath Street estimates.…
Biopharma firm MoonLake Immunotherapeutics (NASDAQ:MLTX) was downgraded to Peer Perform from Outperform at Wolfe Research, citing concerns on overpromised timelines. MLTX down about 2% premarket. “Lacking…
Eoneren/E+ through Getty Images Biotech company Scorpius Holdings (NYSE:SCPX) CEO Jeff Wolf mentioned on Monday in a letter to shareholders that the company has recorded a…
Quest Diagnostics completes LifeLabs acquisition Source: Seekingalpha
STRATA files complaint against three corporations, citing unfair competition in sales of laser devices Source: Seekingalpha